Titus Wealth Management
- SEC CIK
- 0001732007
- Latest filing
- Nov 9, 2022
HQL holding history
abrdn Life Sciences Investors in every 13F filed by Titus Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HQL overviewAll 13F holders of HQLFull Q2 2022 holdings
- Shares (Q2 2022)
- 15,455
- Value
- $220.0K
- % of portfolio
- 0.1%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 15,455 | $220.0K | 0.1% | −7,261−32.0% | Reduced | Holders |
| Q1 2022 | 22,716 | $376.0K | 0.2% | +2,868+14.4% | Added | Holders |
| Q4 2021 | 19,848 | $382.0K | 0.2% | +522+2.7% | Added | Holders |
| Q3 2021 | 19,326 | $401.0K | 0.2% | +375+2.0% | Added | Holders |
| Q2 2021 | 18,951 | $406.0K | 0.2% | +1,896+11.1% | Added | Holders |
| Q1 2021 | 17,055 | $336.0K | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.